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Wear occurs in natural knee joints and plays a pivotal factor in causing articular cartilage degradation in osteoarthritis (OA) processes. Wear
particles are produced in the wear process and get involved in inﬂammation of human knees. This review presents progresses in the mechanical
and surface morphological studies of articular cartilages, wear particles analysis techniques for wear studies and investigations of human knee
synovial ﬂuid in wear of human knees. Future work is also included for further understanding of OA symptoms and their relations which may
shed light on OA causes.
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The knee is composed of the tibiofemoral joint and the
patellofemoral joint. Each joint has cartilage, subchondral bone
and soft tissues at and around junctions. Cartilage, a wear
bearing material, covers the end of bones in the knee joint. The
synovial ﬂuid, contained by the ﬁbrous membrane which is
around the margins of the articular surfaces and the superior
and inferior outer of the menisci, lubricates the articulations.
The synovial membrane provides low friction in the movement
of the joint. The knee joint sustains wear, functioning like a
hinge, and can be ﬂexed and extended when transporting loads
from femur to tibia in the human normal walking process.
Being the largest and most complex synovial joint in the
human body [1,2], it can absorb vertical force of nearly seven
times’ body weight. However, it is vulnerable to horizontal
blows, especially lateral blows to the extended knee, which are
the most dangerous to the joint [3].
Wear occurs to the articular cartilage surfaces in normal
motions of the knee. Wear particles produced from articula-
tions are released into the synovial ﬂuid and may be involved
in the biological activities in the knee [4]. Articular cartilage
has a limited repair capability. If the regeneration cannot keep
pace with the degradation of the matrix due to reasons such as
aging, osteoarthritis (OA) will occur. Other common damages
to the knee are injury to soft tissue at and around the knee
joint, tears of the anterior and posterior cruciate ligaments,
menisci tears and trauma to the collateral ligaments [1].
OA in the human knee, a disease of the organ–synovial joint
[5] and one of the most common forms of arthritis involving
ligaments, periarticular muscle, nerve, bone, meniscus and
articular cartilage [6] is a wear-related disease affecting the
elderly worldwide and also becoming increasingly common
among young people. It is inﬂuenced by many factors [7–9]
including aging, gender, genetics, obesity, occupational factors
and sports participation, and nutritional factors, etc. The disease
is often characterized by the degradation and loss of articular
cartilage, subchondral bone remodeling and inﬂammation of the
synovial membrane. Among these symptoms, the degeneration
of articular cartilage is often used for OA diagnosis.
The Outerbridge scale [10] and Kellgren–Lawrence grading
scale [11] are two systems often used to classify OA severity.
In the Outerbridge scale, grade 0 represents normal cartilage;
grade 1 describes articular cartilage with softening and super-
ﬁcial lesions; grade 2 refers to partial thickness defects with
ﬁssures down to 50% of the cartilage depth; grade 3 describes
severe damage with ﬁssuring reaching the subchondral bone,
and grade 4 refers to fully exposed subchondral bone with
no signiﬁcant articular cartilage left. The Kellgren–Lawrence
system grades OA based on information from X-rays suchas the joint space narrowing, osteophytes, and sclerosis.
In addition to X-ray [12], magnetic resonance imaging
(MRI) [13], radiographic measurement [14,15] and arthro-
scopy [16,17] are often used for OA diagnosis and assessment.
More details of these techniques will be provided in the next
section.
As described above, the OA process involves the damage to
the articular cartilage, the subchondral bone and the synovium,
and is associated with activating the inﬂammatory response of
the human knee [18]. Mechanical wear is a pivotal factor in
causing cartilage degeneration of OA [19,20], in which wear
particles are generated. Wear particles can trigger inﬂammation
of human knee [19]. Investigations to the wear of the articular
cartilage, its by-products and inﬂammation of human knee
caused by wear debris will provide further insights to the wear
process. This review discusses existing studies on wear of
articular cartilages, wear particles analysis techniques for wear
studies in human knee joints and studies of human knee
synovial ﬂuid for OA assessment in the following sections.2. Existing studies on wear of articular cartilage and OA
diagnosis
Articular cartilage covers the ends of bones in the knee joint,
supports and distributes loads and pressure over the surface of
a joint. It can absorb shock during the movement of the joint.
Articular cartilage is a wear-bearing tissue that can withstand
2.5–5 times body weight with little friction and wear during
normal walking [21]. In general, articular cartilage at the
femoral condyles and tibial plateau is 1–3 mm thick [19].
Physiologically, cartilage does not have blood supply, lym-
phatic channels, and nerve innervation [22]. Its cellular density
is less than any that of other tissues. Its unique composition,
structure, and material properties enable articular cartilage to
bear and distribute very high loads at the knee with an
extraordinarily low wear rate and friction coefﬁcient.2.1. Composition and structure of articular cartilages
Water is the most abundant component of articular cartilage
[22], which is mostly concentrated near the articular cartilage
surface (80%), and decreases in an almost linear fashion
with the increments of depth to an approximate concentration
of 65% at the deep zone. Many free mobile cations (e.g., Naþ ,
Kþ and Caþ ) are present in the ﬂuid and greatly contribute to
the mechanical and physicochemical behavior of cartilage.
Approximately 70% of water may be moved when the tissue is
loaded in compression. This interstitial ﬂuid movement is
important in cartilage functions such as transporting transient
loads, dissipating energy and lubrication of the cartilage. Water
Table 1
Risk factors inﬂuencing OA.
Risk factor Relation to OA
Aging Aging and development of OA are closely related [35].
Gender Women over 50 years old have a much higher risk suffering OA than men [8,9].
Genetics Genetic factors contribute to the pathogenesis of knee OA from 39% to 65% [7].
Obesity Obesity antedates the progression and increases the risk of OA [7].
Occupational factors and sports
participation
Athletic and occupational activities involving excessive activity or normal activity acting on a vulnerable joint, and thus the
joint is very susceptible to OA [9].
Muscle weakness May increase the risk of OA progression [7,9].
Acute joint injury and joint
deformity
Cumulative articular cartilage stress over a certain threshold could result in joint degeneration [7].
Local joint vulnerabilities Permanent damage by major injury to a joint or injury close to fractures of a bone on a joint, cause the incipient lesions of OA
[9].
Hormonal status Estrogen may have a protective effect on OA [7].
Bone density High bone mineral density leads to a higher risk of OA, but bone loss causes a progression of the disease.
Nutritional factors High dietary intake of micronutrients could protect against OA [7].
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moving back and forth between the chondrocytes and the
surrounding nutrient-rich synovial ﬂuid.
Chondrocytes and extracellular matrix are important com-
ponents of cartilage [21,23]. Chondrocytes are sparsely dis-
tributed in the extracellular matrix, and make up approximately
10% or less of its volume [19,22,23]. Chondrocytes are
responsible for the synthesis of the matrix, and the matrix
maintains the environment of the chondrocytes. The collagen
network and embedded proteoglycans are the main compo-
nents of the extracellular matrix. The extracellular matrix
determines important properties of cartilage, such as stiffness,
durability, and distribution of load.
Collagen contributes to approximately 20% of the wet
weight of cartilage. The collagen ﬁbers usually have an
average diameter of 25–40 nm [22] and in human up to
150 nm. Type II collagen is the primary collagen in cartilage,
and constitutes of 90–95% of the total [24]. Other types of
collagen such as types V, VI, IX, XI, only account for a minor
amount and may relate to the formation and stability of type II
collagen. Collagen ﬁbrils are strong in tension but weak
in compression because their large slender ratio, the ratio
of length to thickness, makes them easy to buckle under
compressive load. The arrangement, density and interactions of
collagen–PG are inhomogeneous in articular cartilage and
contribute to the tensile anisotropy of articular cartilage,
meaning that its material properties relate to the direction of
loading.
Proteoglycans form the major macromolecule of cartilage
ground substance and account for 10–15% of the wet weight
[25]. Proteoglycans can interact with tissue ﬂuid. Therefore,
they can give cartilage stiffness to compression and resilience
and contribute to its durability as a joint surface. The
negatively charged glycosaminoglycan chains can attract
positive ions. Compression may drive the glycosaminoglycan
chains closer together, increasing their resistance against
further compression and forcing more ﬂuid out of the
molecular domain. Release of the pressure allows the mole-
cules to expand again. Fully expanded proteoglycans in thecartilage matrix can occupy many times greater volumes than
the volume of the tissue that contains them. Therefore,
proteoglycans in the matrix must be partially hydrated and
produce a constant pressure to expand, restrained by the
collagen ﬁbril meshwork. Thus, once the collagen network is
disrupted, the matrix swells as proteoglycans expand, increas-
ing the concentration of water and decreasing the proteoglycan
concentration.
The structure of the articular cartilage extracellular matrix is
inhomogeneous and can be divided into four layers along the
direction from the superﬁcial surface to the subchondral bone
[26]. The gliding surface of a normal joint is the superﬁcial
tangential zone. The superﬁcial tangential zone accounts for
10% of the whole thickness of articular cartilage. Beneath the
most superﬁcial layer, the ﬁbers are tangential to the surface
and the chondrocytes are discoidal with the long axis of the
cells parallel to the surface. Proteoglycans associated with
collagen in this zone resist extraction more than those in other
zones, suggesting a stronger association between collagen and
proteoglycans in this zone. It is possible that a stronger
association of the matrix macromolecules helps the superﬁcial
zone matrix to resist the shearing stresses in joint motion. The
middle zone forms 40–60% of the cartilage volume. The cells
are more spheroidal than those in the superﬁcial tangential
zone. Collagen ﬁbers in this zone are larger than those of the
superﬁcial zone. The deep zone comprises 30% of the cartilage
volume. A tighter meshwork with the ﬁbers is radial to the
articular cartilage and the cells are spheroidal and contain 4–8
cells in the columnar. The collagen ﬁbers are the largest and
the proteoglycans are the most abundant and the water content
is the lowest in the deep zone. The calciﬁed cartilage zone
separates cartilage and subchondral bone. The calciﬁed zone is
heavily impregnated with crystals of the calcium salts and
there are few cells in this zone. Beneath the cartilage,
subchondrodral bone connects the cartilage and bone.
Differences in the matrix composition and structure among
the zones summarized above may determine their differences
in mechanical function. The superﬁcial zone is primarily
responsible for resisting shearing load. The middle zone may
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being parallel to the cartilage surface to being vertical in the
deep zone. The deep zone may resist compression load. The
zone of calciﬁed cartilage would then provide a transition in
material properties between hyaline cartilage and bone, and
anchor the hyaline cartilage to the bone [27].
2.2. Wear of articular cartilage and OA
2.2.1. Wear of articular cartilage
In knee joints, cyclical variation of the total joint load in
most physiological activities leads to repetitive stressing of
cartilage [22]. During rotation and sliding, a particular region
of articular cartilage surface suffers stressing repetitively. In
that speciﬁc area, repeated joint movement and stressing result
in repetitive stressing of the solid matrix and repeated
exudation and imbibition of the tissue’s interstitial ﬂuid. These
processes increase the possibility of the disruption of the
collagen–PG and of PG “washing out”. Repeated collagen–PG
stressing disturbs the collagen ﬁbers, the PG macromolecules,
and/or the interface between the two components.
One typical defect is splitting of the cartilage surface.
Fibrillation often shows splitting lesions through vertical
sections of cartilage. These splits eventually develop and
extend to the full depth of the articular cartilage. Erosion of
articular cartilage layer is another common defect.
Once the collagen–PG matrix of the cartilage is disturbed,
damage from any of the three mechanisms may occur [22]: (1)
further disruption of the collagen matrix due to repeated
stressing; (2) an increase in PG washing out resulting from
the violent movement of interstitial ﬂuid and impairment of
articular cartilage’s interstitial ﬂuid load support capability;
and (3) gross change of the load carriage mechanism in the
cartilage and an increase in frictional shear loading on the
articular cartilage surface. All these processes accelerate the
rate of interfacial and fatigue wear of the already damaged
cartilage microstructure.
The tribological response of the natural medial compart-
mental bovine knee was investigated in the wear of the
opposing femoral cartilage [28]. Strong correlation was shown
between stress and wear and between friction shear stress and
wear. A tribological simulation of the medial compartmental
bovine knee was carried out to study the friction and wear with
and without meniscus [29]. The results revealed that increased
contact stress and frictional coefﬁcient upon removal of the
meniscus caused immediate surface ﬁbrillation, biomechanical
wear and permanent deformation of cartilage.
2.2.2. OA causes, symptoms and existing diagnosis techniques
OA process involves mechanical, biological, biochemical,
molecular and enzymatic feedback loops [7,13]. OA is widely
thought to be induced by mechanical factors [7,12,30]. OA can
also be understood as the degeneration and loss of some
macromolecules due to direct and indirect factors (Table 1) at
the molecular level [5].
Patients felt pain, constrained physical activities (e.g.,
bending down), while some patients felt pain or discomfortwith movement. Patients suffering severe OA feel stiffness and
pain in movement, low mobility and knee lock. It has been
found that the pain does not originate from cartilage because
there are no pain receptors in cartilage. Pain is suspected to be
stimulated by the A delta mechanoreceptors and the C
polymodal nerve endings in the synovium and surrounding
tissues [31].
The symptoms of OA often include a decrease in joint
space, eburnation (joint sclerosis), osteophytosis (small bony
outgrowth), and bony cyst formation. In severe degeneration,
misalignment of the knee joint may also be observed. At this
time, the joint’s movements become severely limited, often
causing great pain to the patients. Wear of articular cartilage is
an important symptom of OA [32] and the severity of wear is
often used for OA assessment.
The techniques often used to diagnose knee OA are X-ray,
MRI and arthroscopy. X-ray is a frequently used method for
diagnosing osteoarthritic changes in knee joints [12]. Radio-
graphic measurement can detect changes in joint space [14,15].
However, radiographic measurement is insensitive to early OA
[33,34]. MRI quantitatively assesses intra-individual cartilage
volume/thickness changes over time in healthy joints and
joints with OA [13], but the process is expensive and time-
consuming [33].
MRI does not provide information on the changes in the
mechanical properties of knee joints [33]. Arthroscopy is
another commonly used method to diagnosis and treatment
of knee OA [16]. A video camera on the arthroscope provides
direct information about the condition of the joint. However, it
is invasive due to the nature of the surgical procedure of
arthroscopy [16,17]. Specialist and anesthetic services are
needed in the arthroscopy procedure. More recently, a
mechanical measurement has also been explored, but not
applied broadly due to its high cost and lengthy process
[33]. Spectrocolorimetric evaluation correlates cartilage degen-
eration to OA but requires further development to be employed
as a tool for diagnosis [36].2.2.3. Changes in composition and structure of articular
cartilage in OA process
Cartilage exhibits a balance between the anabolic and
catabolic processes. In OA, the balance gets disturbed resulting
in the destruction and loss of cartilage. As OA progresses,
proteoglycan starts to deplete, followed by degradation of
collagen II, which results in mechanical failure and ultimately
complete erosion of the articular cartilage [10]. The full
thickness of cartilage and the underlying bone are affected,
contributing to all aspects of the disease process. The
hypothesized mechanisms of the damage to the collagen
network and subsequent matrix loosening can be explained
from their biomechanical and biochemical origin. Excessive
mechanical stresses cause collagen ﬁbril disruption. The
disruption of the collagen–proteoglycan interaction sites con-
tributes to the degradation. The changes in the molecular
structure and disaggregation of proteoglycans are responsible
for the degeneration.
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cartilage are important symptoms of the disease [8]. The
morphology and metabolic structure of chondrocytes, as well
as biochemical properties and structure in the extracellular
matrix macromolecules [13] are altered due to OA. Cartilage
fragments produced from the articulating process in knee joint
are released to the synovial ﬂuid or other body ﬂuid [37]. The
fragments in the synovial ﬂuid contain some information about
the degenerative changes of articular cartilage [4].
Changes in the morphology and biomechanical properties of
articular cartilage occurred in OA process, and these changes
can assist in detecting cartilage degeneration. When cartilage
degenerates, damage to the surface becomes more evident with
OA progression [38]. This form of cartilage degeneration has
been quantitatively characterized [39]. In addition, cartilage
usually softens and ﬁbrillates with degeneration [2]. The
change in stiffness of cartilage can also be observed at both
the millimeter [40] and nanometer scales [10].
2.3. Biomechanical properties of articular cartilage
Earlier mechanical property investigations on cartilage were
carried out at macro- or micro-length scales in compressive,
tensile and indentation testing. Existing compression and
indentation tests often used large loads (e.g., 1.8–11.8 N [41],
and 10 N [42]) to study the mechanical properties of articular
cartilage. In these measurements above, relatively large tips
were used with radii of millimeter dimensions (e.g., 0.4 mm
[43], 0.5 mm [44] and 1 mm [40]). These approaches using
millimeter tips resulted in deformations in the order of hundreds
of micrometers (e.g., 40–190 mm [45], 300 mm [42]). At these
scales, the average mechanical properties of the tissue over a
large volume, i.e., over several mm3 of material were measured.
Therefore, local variations in cartilage properties may not be
detected using the clinical indentation testing procedures. For
example, there was no signiﬁcant difference between the normal
and osteoarthritic cartilages reported in [46].
The unconﬁned compression test revealed that the mean
Young’s moduli for healthy bovine humeral, patellar and
femoral cartilages were 0.8070.33 MPa, 0.5770.17 MPa
and 0.3170.18 MPa [47], respectively. An average value of
Young’s modulus of healthy human patella cartilage samples
was reported to be 0.6470.30 MPa, measured using uncon-
ﬁned compression testing [40]. This study also reported that
early degenerated cartilages had a mean modulus value of
0.7070.62 MPa and the mean modulus of advanced degen-
erated cartilages was reduced to be 0.2170.26 MPa.
In the past 10 years, studies on the nano-mechanical
properties of cartilages have been carried out based on the
recent ﬁnding that the pathological changes of the cartilage
degeneration start at a nano-scale [10]. A nanometre-sized
atomic force microscope (AFM) tip, which is smaller than the
diameter of a collagen ﬁber, can sense the local variations in
stiffness of the three-dimensional organization of collagen
ﬁbers and proteoglycans. Young’s modulus of the ﬁbrocarti-
lage from the articular condyle of rabbit jaw joints [48] and
Young’s modulus of the rabbit proximal radius condylecartilage using a tip with a radius of 20 nm [49] were
measured. Peng’s group at the University of New South
Wales, Australia, investigated Young’s modulus of unworn
and worn articular cartilage extracted from rear sheep leg at
indentation depth within a range of several hundred nan-
ometers [50]. After subjected to a series of separated wear
tests, the effective indentation modulus of articular cartilage
showed a softening trend in the initial wear phase and then a
stiffening trend in the late wear phase measured by AFM
operated in a ﬂuid mode to indent cartilage. Sneddon model
was used to ﬁt the force–distance curve. The results indicated
that the cartilage may have a relatively stiffer top layer
compared to the inner surfaces.
Very limited work has been done on human cartilage at a
nanometer scale. Stolz et al. are one of the few researchers and
pioneers in using AFM to investigate the mechanical properties
of human cartilage surface due to OA [10]. In that work, an
applied load of 3 μN was used resulting in an indentation
depth of 2 μm. A decreasing trend of the nano-stiffness was
observed from healthy cartilages to OA grade 3 cartilages.
Wen et al. [51] studied the elastic modulus of collagen ﬁbrils
of healthy and diseased (OA grades 1–3) cartilages and found
that the individual collagen ﬁbril of an OA cartilage was much
stiffer than that of the healthy ones with an intact collagen
structure. Peng’s group used AFM to measure Young’s
modulus of human knee cartilages with different OA grades,
and found that Young’s modulus measured at indentation
depths (300 nm and 1000 nm) increased from the healthy
cartilage to the mildly worn cartilage and decreased in the
severe condition [52]. The results indicated that as OA
progressed, the cartilage surface stiffened at an early stage of
OA and became softer with advanced OA. Accompanied to the
changes occurred to the effective indentation modulus, the
nano-structure of the cartilage surface altered as well evi-
denced by the AFM images.
Existing works report that several issues need to be
considered in tissue indentation testing [53]. Firstly, the initial
contact point of the tip-sample in indentation testing is difﬁcult
to detect for soft tissues. The problem can be solved by
calculating the area under the load–displacement curves that
correspond to the work done by the cantilever. Secondly,
quantitative estimation of the mechanical properties based on
statistical analysis of many repeated measurements is needed
because the biological tissues are highly anisotropic and
inhomogeneous. Thirdly, the nanometer scale properties of
cartilage can be different from properties at the millimeter or
micrometer scales.
2.4. Surface morphological properties of articular cartilage
and their changes in the OA process
The surface morphology of articular cartilages plays an
important role in joint lubrication and wear-bearing properties.
Existing studies on this topic can be grouped according to
objects (animal vs. human samples), techniques for examining
and imaging surface morphologies and/or characterization
scales (millimeter, micron and nanometer). The following
Fig. 1. AFM images of wear particles found in knee synovial ﬂuid samples collected from severe osteoarthritic patients (OA grades 3 and 4). (a) An irregular
shaped wear particle; (b) a square wear particle with a smooth surface; (c) an irregular and rough particle; and (d) rough particles.
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animal samples followed by human specimens. Different
techniques and their resolutions are included in the following
sections.
Cartilage surface alterations of animal samples were inves-
tigated at a micrometer scale using high frequency ultrasound
[54], optical proﬁlometry [55], scanning white light interfero-
metry [56], and laser scanning confocal microscopy (LSCM)
[57,58]. Graindorge et al. found that changes occurred in the
surface morphology of the articular cartilage of sheep leg
during wear [38]. Peng’s group compared the surface morphol-
ogies of unworn and worn articular cartilage from sheep rear
legs at both micro- [58] and nanometer scales [59]. Different to
previous studies, numerical parameters, including the ﬁeld and
feature parameters deﬁned in ISO/FDIS 25178-2 [60], wereutilized to describe the surface topographies and their changes
with the wear process. Field parameters provide information
about height amplitude, spacing frequency or hybrid geometric
information of a surface using a statistical analysis of a cloud
of points [61]. Feature parameters can reveal functional related
properties of surfaces.
Micro-scale study revealed that selected ﬁeld parameters can
reveal the wear trait of cartilage surface in the wear process,
while selected feature parameters can describe the relations
between surface features and wear properties of cartilage
surface [58]. The characterization of the surface topographies
of the unworn and worn sheep cartilages was conducted at a
nanometer scale [59]. Different to the micro-scale studies, the
nano-surface topographies were obtained using AFM. The
results showed that selected parameters revealed the changes in
M.L. Wang, Z.X. Peng / Biosurface and Biotribology 1 (2015) 98–112104the cartilage surface morphology at the nanometer scale, and
the nano-scale characteristics of cartilages altered with the
evolution of the wear process. The innovation of this study
was that feature parameters were applied to reveal functional
related properties of cartilage surfaces at a nanometer scale.
In parallel to the mechanical and surface topographical
studies on unworn and worn animal (sheep) cartilages, Peng’s
group carried out immunohistochemical analysis of structural
changes in collagen of articular cartilage for better under-
standing of wear progression [62]. The collagen networks of
cartilage were gradually disturbed with wear progression
observed from micrographs showing stained cartilage collagen
networks. The alterations in the collagen structure may cause
the changes in the mechanical property and surface morphol-
ogy of cartilages in the wear process.
In addition to studies using animal models, wear of human
cartilage surfaces was observed using MRI [63–69], arthro-
scopy [70,71] and polarized light microscopy [72–74]. MRI is
widely used to examine cartilage thickness. The above
examinations to cartilage surface changes were carried out at
a millimeter scale. These studies also reveal that obvious
changes to the cartilage surface have already occurred in
osteoarthric cartilages when measured at the millimeter scale.
To study pathological changes in cartilage at the nanometer
scale, scanning electron microscopy (SEM) and AFM are the
two commonly used techniques. Standard SEM requires
dehydration of the specimens together with its incapability of
acquiring mechanical data and its difﬁculties to obtain quanti-
tative 3D surface data [75]. AFM was used for cartilage studies
[76–78]. The majority of the existing work on AFM was nano-
mechanical property studies.
Limited work was carried out on the surface morphologies of
human cartilages and most of them were qualitative or using
surface roughness parameter (Ra) [63,79]. Reported surface rough-
ness data of healthy and osteoarthritic cartilage surfaces exhibited
differences in these studies. For instance, the measurements
showed that the mean surface roughness values of smooth,
intermediate, and rough cartilage samples were 7.973.3,
29.177.8 and 49.1 μm, respectively, when using high frequency
ultrasound [54], while using scanning white light interferometry,
the average surface roughness values of human cartilage samples in
OA grades 0, 1 and 2 were 0.8070.3, 1.070.3 and
1.7070.9 μm, respectively [56]. Surface roughness was reported
to be 30 μm for a healthy condyle with a smooth surface [55]. It
can be concluded that different measurement techniques and
sample preparation methods can lead to a large variation in the
surface roughness measurement results. Up to date, very limited
surface parameters have been used to describe the cartilage surface
and its change in OA. The surface roughness Ra is the most
commonly used parameter. As we know the limitation of this
descriptor, there is a possibility that pathological changes in the
cartilage cannot be fully revealed by Ra. Thus, further development
needs to be advanced in order to characterize the nano-scale
changes in the surface topographies for OA understanding and
early diagnosis.
To address the limitation of using one parameter to describe
surface changes in the OA process, work [80] developed atechnique for numerically characterizing the surface topogra-
phies of human cartilages and their changes at both a micron
and submicron scale. High-quality three-dimensional images
of human cartilage surfaces were obtained in a hydrated
condition using laser scanning microscopy and AFM. Using
the numerical data extracted from improved image quality and
quantity, it can be seen that OA evolution can be identiﬁed by
speciﬁc surface features at a micrometer scale, which are
amplitude and functional property related. At the submicron
scale, the spatial features of the surfaces could distinguish the
early OA grade from advanced OA ones. The established
techniques in [80,81] could allow quantitative investigations of
distinctive alterations in human cartilage surface and better
understanding of wear changes in human knees.
2.5. Summary
From the above review, it can be drawn that the unique
composition and structure of articular cartilage makes it an
almost frictionless wear-bearing material. Once an articular
cartilage subjects to OA, proteoglycans starts to deplete,
followed by the degeneration of collagen and ﬁnally causing
the mechanical failure of the articular cartilage and the
underlying bone.
Nowadays, it is realized that the degradation of knee joint in
OA starts at the nanometer scale, but the investigations to the
biomechanical properties and surface morphologies of articular
cartilage due to OA were carried out from macro, then micro-
and down to nanometer scales. Correspondingly, the studied
mechanical properties also reﬂect the overall structure of the
articular cartilage to the ﬁne nanometer scale structure. The
sharp AFM tip depicts the elastic properties of the ﬁne
structure of the cartilage, whereas micrometer and larger-
scale tests measure its overall structural stiffness. The nano-
scaled stiffness is different compared to the overall structural
stiffness due to the ﬁne nanometer scale structure.
The mechanical properties of articular cartilage can vary
signiﬁcantly when measured in different conditions, including
the sample hydration status, indentation depth, tip shape and
size, loading rate and magnitude. Most of the current studies in
characterizing the mechanical properties of articular cartilage
focused on measuring the mechanical property. Future studies
should put more efforts in the interpretation in observed
changes in the mechanical properties of diseased articular
cartilages. One of main challenges is that human samples are
limited and often difﬁcult to obtain. Also, the measured
mechanical properties can be different from individuals to
individuals, evidenced by the fact that different changes in
measuring stiffness of human cartilage in OA process were
observed when examining in similar conditions.
The investigations of the surface morphologies of human
cartilages were performed from micrometer, then micrometer
to nanometer scales, evolving from two-dimension to three-
dimension using different imaging techniques. The character-
ization of the surface morphologies evolves from being
qualitative to quantitative. The current studies showed that
micro-scale quantitative studies performed on three-dimension
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and functional properties of cartilage surface for OA assess-
ment. Future studies may further develop effective and
objective diagnostic techniques at the micrometer scale.
3. Wear particle analysis techniques for wear studies of
human knee joints
Wear particles, as shown in Fig. 1, found in human knee
joints are by-products of cartilage in the wear process. Wear
particles carry rich information on knee joint conditions and
wear mechanism of human knee. Biological wear particles
may participate in the pathogenesis of degenerative arthritis
[4]. Wear particles could be phagocytosed and participate in
producing and activating of lysosomal enzymes. Wear particles
may also play an important role in inducing other cellular or
humoralinﬂammatory responses. Investigation to feature of
wear particles assists understanding wear in the human knee.
3.1. Preparation techniques of biological wear particles
The ﬁrst step in analyzing wear particles found in the human
knee is isolating them from the synovial ﬂuid. Ferrography,
bio-ferrography and ﬁltergram are three commonly used
methods to prepare wear particles. The validity of these
preparation methods to prepare human wear particles is
discussed below.
Ferrograhy is used to prepare wear particles found in human
and sheep knee joints [4,38,82]. Initially, ferrography is an
industrial approach which is used to separate ferrous debris
from the lubricant. The main principle of ferrography is based
on the magnetic precipitation of particles from suspension. The
largest particles and particles with high magnetic susceptibility
are deposited at ﬁrst on the substrate and graded according to
the size along the length of the ﬂow path [83]. Particles need to
have a positive volumetric magnetic susceptibility of the order
of 50 106 or more to be deposited in ferrography. This
approach was applied to prepare wear particles found in
synovial ﬂuid to study wear in human knee joints [4,83–88].
Wear particles found in human knee joints do not have positive
magnetic susceptibility. Wear particles need to be magnetized
using erbium chloride [89], which might change particle
properties, especially their mechanical properties. Moreover,
particle overlapping is often a major problem associated with
this method, making it difﬁcult to examine individual particles.
Bio-ferrography is a modiﬁcation of ferrography which
allows magnetic isolation of target cells and tissues [90,91].
It allows any ﬂuid sample, including whole blood, to be
analyzed. Bio-ferrography was applied to separate wear
particles in human knee joints [90,91]. However, bio-
ferrography may experience similar problems with ferrogra-
phy. In particular, the magnetization process (e.g., magnetized
with ErCl3 [90]) may denature of the wear particles, especially
altering the biomechanical properties of wear particles.
Filtergram is a technique in which a ﬁlter membrane is used
to separate and collect wear particles from synovial ﬂuid.
Investigations of the size and shape of individual wearparticles are allowed as the particle overlapping problem in
the ferrography can be signiﬁcantly minimized or eliminated. It
has been applied to investigate metallic wear particles [92] and
ultrahigh molecular weight polyethylene wear particles found
in knee prosthesis [93], as well as to wear particles found in
sheep knee synovial ﬂuid [39,94]. Caution is needed when
applying this technique because the ﬁlter membrane may be
ruptured due to a large applied force. Or the membrane may
become blocked by wear particles.
Immobilizing wear particles onto a substrate to prevent
movement during AFM investigation was used to be a
technical challenge in preparing wear particles. In speciﬁc,
the challenges for wear particle mechanical analysis are: (1) to
develop particle separation techniques for individual particle
measurement at the nanometer level, and (2) to generate a
robust method for the immobilization of particles to avoid
dislocating the particles. A breakthrough in preparing human
wear particles was made for AFM measurement [89]. In their
study, a preparation technique to securely deposit and adhere
human wear particles to a ﬂat and smooth substrate for AFM
analyses has been developed.
3.2. Image acquisition techniques of biological wear particles
The image acquisition techniques to obtain shapes and
morphologies of biological wear particles are reviewed below.
The shapes and morphologies of human wear particles may be
potentially obtained using commonly used image acquisition
techniques such as electron microscopes and LSCM.
Available electron microscopes, such as SEM and environ-
mental scanning electron microscopy (ESEM), are used for
investigations of wear particles. For example, SEM was used
to obtain surface shape information of human wear particles
[82]. To be imaged by SEM, wear particles need to be coated,
which may alter their surface topography. The mechanical
properties cannot be measured by SEM. Dehydration is
another issue using SEM. ESEM has been used to capture
the shape of wear particles and the surface morphology of
articular cartilage from sheep knee in a hydrated environment
[38]. However, these techniques provide surface morphology
information in two dimensions rather than appropriate surface
topography in three dimensions for quantitative analysis.
LSCM can capture surface topography in three dimensions.
LSCM is able to capture the boundary and surface information
of the wear particles at a micrometer scale. LSCM was used to
acquire the 3D surface information of sheep wear particles
[94].
AFM can acquire 3D data of biological materials with
resolution at a nanometer in a hydrated status. AFM imaged
subnucleosomal particles [95] and hepatitis B virus [96]. Using
the preparing technique reported in [97], AFM was ﬁrstly
applied to human wear particles. The 3D surface topographies
and nano-mechanical properties of hydrated human wear
particles were investigated. The maximum vertical range of
AFM is within 4–6 mm, which is smaller than average size of
particles [98]. For this reason, AFM may be limited in
investigating the boundaries of thick human wear particles.
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particles
Important features of wear particles such as their size, shape
and surface topography may be obtained from the imaging
techniques discussed above. Numerical characterization of
these features allows analysis of whether the surface morpho-
logical information of wear particles directly correlates to knee
joint conditions.
The size of wear particles can be characterized using the
minor axis length and major axis length, contact area and
perimeter [99]. The shape of wear particles can be described
using elongation roundness, compactness, integrated density
per contact area, boundary fractal dimension, convexity and
shape factor [84,99]. These numerical parameters can describe
the size- and shape-related properties of human wear particles.
Surface topography is a critical factor and an important
functionality indicator in the performance of a system [100].
Surface topographical properties can be characterized by two
sets of parameters, namely, ﬁeld and feature parameters, which
allow a numerical description of a surface topography. A ﬁeld
parameter is deﬁned from the continuous sub-set of points
from the scale limited surface [60]. A feature parameter is
deﬁned from a subset of predeﬁned topographic features from
the scale limited surface [60]. These numerical parameters
were applied to characterize the matt ﬁnish femoral stem
surfaces [61], surfaces of hard on hard bearings in prosthetic
hip joints, cartilage surface [58], and wear particles found in
sheep knee joint [94]. The surface topography of human wear
particles may be described using the ﬁeld and feature
parameters deﬁned in ISO 25178-2.
Field parameters include height, spatial, hybrid, miscella-
neous, functions, and related parameters [60]. Height-related
parameters give information about the statistical average
properties, the shape of the height distribution histogram.
Spatial parameters reveal the peak density, texture strength
and dominant texture direction. Hybrid parameters describe the
slope gradients of a surface and their calculations, which are
based on local z-slopes. Functional parameters can characterize
bearing and ﬂuid retention properties of a surface.
3.4. Current understanding distinct features of human wear
particles
Wear particles in a healthy knee joint are usually small,
smooth, and have a simple structure. However, in osteoarthritic
joints, wear particles are chunky, rough, and complex in
structure [84]. The current understanding of the key features
of human wear particles and their correlation to knee joint
conditions are summarized as below.
The reported size of wear particles found in normal
and osteoarthritic human knee joints ranges from 0.54 mm
to 286.3 μm [82]. The mean size of wear particles in
osteoarthritic joints is larger than that in the healthy joint.
Small particles are the most abundant in healthy joints and
there are more large particles in osteoarthritic joints than in
healthy joints. The size of human wear particles inosteoarthritic synovial ﬂuid spreads wider than that in normal
synovial ﬂuid [99].
The shapes of human wear particles were numerically
characterized and correlated with osteoarthritis severities
[84]. Leaf-like wear particles are found in healthy knee joints.
Elongated and rod-shaped wear particles are most abundant in
knee joints with early stage OA. Irregular shaped and chunky
wear particles are found in knee joints with late OA. Osseous
wear particles can be found in osteoarthritic knee joints with
subchondral bone exposed. The quantitative analyses of the
shapes of wear particles were characterized using the area,
length, convexity, elongation, shape factor, and fractal dimen-
sion [84,99]. The numerical results reveal that the numerical
descriptors (the area, length and fractal dimension) showed a
smaller range of values obtained from healthy joints than the
same descriptors computed from particles found in knee joints
with OA. Wear particles found in osteoarthritic knee joints are
statistically longer and showed a large area. The boundary
fractal dimension is signiﬁcantly higher for wear particles
found in osteoarthritic knee joints in comparison to those from
healthy joints. The elongation factor is signiﬁcantly larger for
wear particles found in early OA than those in healthy knee
joint. Higher fractal dimensions and lower convexities are
found for wear particles in late OA knee joints than those in
early stage of OA.
The surface topographies of wear particles contain informa-
tion on particle formation [94] and the wear mechanism of the
knee joint [4]. Few studies have investigated their surface
topographies and their relation to osteoarthritis severity of the
human knee joint. These gaps are due to the limitations of
acquiring appropriate 3D surface data with high resolution, and
ineffective numerical descriptors on surface topography [98].
Height parameters have successfully been used to characterize
wear particles found in sheep knee synovial ﬂuid and correlate
to the joint conditions [39]. The surface anisotropy and
directionality of wear particles from healthy and osteoarthritic
joints have been successfully characterized using the Hurst
orientation transform method [101]. In the Hurst orientation
transform, all pairs of pixels in a circular region are searched to
reveal surface anisotropy. Furthermore, wear particle morphol-
ogy has been investigated on scale-invariant based on a
Partition Iterated Function System (PIFS), by providing full
information about the 3D surface topography wear particles
[98,102,103]. Feature parameters which are more diagnostic
and parameters of functional topographical features of surface
are not used in characterizing human wear particles.
The mechanical properties of wear particles such as Young’s
modulus, adhesion and friction, and their changes in the wear
processes were rarely studied although they could assist in
understanding the degradation processes and may be used in
OA assessment and diagnosis. This is mainly due to the lack of
a suitable wear particle preparation method, especially immo-
bilizing wear particles onto a substrate to prevent movement
during investigation. As reviewed in Section 3.1, developing a
particle separation and immobilization technique for AFM
investigation was a technical challenge for AFM measuring
wear particles in human knee joints.
M.L. Wang, Z.X. Peng / Biosurface and Biotribology 1 (2015) 98–112 107Wang and Peng used AFM to study the nano-surface
topographies, adhesion and Young’s moduli of wear particles
in their hydrated status [104]. It is a pilot study of AFM
applied to wear particles. The results revealed that Young’s
moduli of wear particles generally increased with OA progres-
sion. The adhesion showed a rising trend in the early stage of
OA. The ﬁndings may indicate that the mechanical properties
of wear particles may be used to aid assessing OA severity.
They also investigated the evolution of the nano-surface
topographies of human wear particles in their hydrated status.
It was found that selected numerical parameters are effective in
describing the changes in the surface features of the wear
particles at late OA grades may aid for OA assessment of a
severe OA condition. To further understand the effectiveness
of wear particles in revealing the wear condition of human
knee, the correlation of the mechanical properties and surface
topographies of wear particles was carried out with those of
human cartilages in osteoarthritis (OA) progression. They
provided preliminary results about their correlations and
evidence for further investigations. For the ﬁrst time, Young’s
moduli of human wear particles and their changes in OA
progression have been investigated. It is worthwhile to
mention that it is important to compare Young’s modulus
results of the particle and those of the cartilages under the same
measurement conditions.
3.5. Comparison of human wear particles and those of
polyethylene in artiﬁcial joints
Artiﬁcial joints are now widely served as a treatment to joint
diseases such as OA. Different bearing material combinations
have been used in making artiﬁcial joints. Ultra high molecular
weight polyethylene (UHMWPE) against cobalt–chromium is
the mostly used as the bearing material combination. However,
the major problem in artiﬁcial joints is loosening of the
prosthetic components due to wear [105]. Wear debris are
largely produced at the articulating surfaces. Different to wear
occurred to in human knees, metallic ions in artiﬁcial joints
may be produced in the process of corrosion.
Wear products in artiﬁcial joints may induce biological
reactions [106–108], such as irritation and the local accumula-
tion of macrophages and osteoclasts [109]. Some work
reported that particles in the size range of 0.1–1 mm were
the most biological active [107]. Nano-sized wear debris found
in artiﬁcial joints have been analyzed [110–112]. In contrast,
most studies investigating wear debris found in human knees
ranged at micrometer levels. The role of nano-sized particles
found in human knees should be investigated in future work.
3.6. Summary
Important features of wear particles, namely, particle con-
centration, size distribution, shape, surface morphology and
mechanical properties have been studied using available
techniques for understanding wear in the human knee. Current
studies focused on the micrometer-sized wear particles. In the
future, wear particles in a submicron size should also beinvestigated for understanding wear in the human knee. In
addition, biochemical analysis of wear particle components
may provide an insight into the breakdown of cartilage in the
wear progression of human knee and needs further research.
4. Studies of human knee synovial ﬂuid for OA assessment
4.1. Analysis of cytokines and wear particles in OA process
Inﬂammation of the synovial membrane/synovitis is one of
the main characteristics of OA even in early OA. Cytokines
may play an important role in OA [113]. Some cytokines can
inhibit production of the cartilage matrix and therefore
inﬂuence the balance between synthesis and degradation of
the tissue matrix [18]. Cytokines are grouped as being
anabolic, catabolic, anti-catabolic and modulatory, depending
on their activities on chondrocyte function at the articular
surface [114]. Anabolic cytokines act to promote the synthetic
activity and include insulin-like growth factor and transform-
ing growth factor β. Catabolic cytokines promote matrix
degrading and include interleukin-1 alpha and beta (IL-1α
and IL-1β), interleukin-6 (IL-6) and interleukin-8 (IL-8). Anti-
catabolic cytokines inhibit the activity of catabolic cytokines
and include interleukin-4 (IL-4), interleukin-10 (IL-10) and IL-
1 receptor antagonist (IL-1ra). Modulatory cytokines can
change the activity of other cytokines and include IL-11 [114].
IL-1 promotes the production of matrix metalloproteinases
(MMPs) and prevents the synthesis of cartilage and proteogly-
cans [115,116]. It is most effective in the superﬁcial layer
[115]. IL-6 is a pro-inﬂammatory cytokine and activates the
transcription of its target genes [18]. IL-6 arises from the
synovial lining [117]. The role of IL-6 in cartilage pathology is
unclear [13]. IL-8 promotes pathogenic processes including the
homing of mononuclear leukocytes into the synovium, pro-
motes the activation of these cells, induces synthesis of MMP-
13 in articular chondrocytes, and promotes chondrocyte
apoptosis and loss of proteoglycans [118].
The alteration of cytokines’ proﬁles is likely to reﬂect
inﬂammation [119]. Cytokines released from the inﬂamed
synovium contribute to further degradation in OA [18]. For
example, IL-1β suppresses the anabolic mechanism in the
cartilage by inhibiting the expression of type II collagen and
proteoglycans in chondrocytes. IL-6 has been reported to
inﬂuence the anabolic process in the cartilage by inhibiting
the expression of type II collagen. IL-6 suppresses the
synthesis of other inﬂammatory cytokines and causes hepatic
production of acute-phase proteins such as C-reactive protein
(CRP). Other pro-inﬂammatory cytokines such as IL-8 and
anti-inﬂammatory cytokines such as IL-4 and IL-10 play roles
in chondrocyte metabolism and the development of OA.
The levels of cytokines found in normal and osteoarthritic
human knee synovial ﬂuid change. For example, IL-1 exists in
the synovial ﬂuid and cartilage surface in OA [115]. IL-6
activity in synovial ﬂuid in OA patients has been reported
[18,120]. Elevated concentrations of IL-6 have been found in
OA patients [113]. MMPs promote breakdown of cartilage and
are involved in the progression of OA as MMPs are
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Higher levels of tumor necrosis factor alpha (TNF-α) receptors
were observed in osteoarthritic cartilage than in normal
cartilage [121]. However, few studies have been conducted
on the levels of other cytokines such as IL-2 and IL-8 in
relation to OA and whether their levels can reﬂect knee joint
conditions and the effectiveness of disease diagnosis.
Wear particles can trigger synovial inﬂammation in human
knees [19]. Few studies have studied the relationships between
the features of wear particles such as size, shape, surface
topography and stiffness with the severity of the inﬂammation
in the OA progression. As OA process involves metabolic,
biochemical and biomechanical factors [13], investigations of
the relationships between the features of wear particles and the
levels of cytokines in human knee synovial ﬂuid could provide
insights into the OA process.
The levels of IL-6 and IL-8 in osteoarthritic human knee
synovial ﬂuid were analyzed, and their relations with the
characteristics of wear particles were investigated [122]. It was
shown that the size, adhesion and nano-surface roughness of
wear particles had medium strong to strong correlations with
IL-6 and IL-8. These results indicated that the characteristics of
wear particles contain valuable information for grading the
disease process and there is the need for further evaluation of
the association of properties of wear particles and the
inﬂammatory process. To the authors’ knowledge, this was
the ﬁrst investigation to the relations between wear particles
and inﬂammation cytokines (IL-6 and IL-8) in OA process.
The ﬁndings in this study indicate that selected properties of
wear particles in human osteoarthritic knee joints may inﬂu-
ence the disease process.
OA is a complex process which involves mechanical,
biochemical and biological factors. IL-6 can result in destruc-
tion of knee joint and cartilage, while IL-8 could promote loss
of proteoglycans and recruitment of inﬂammatory cells to the
site of inﬂammation. Therefore, it can be seen that both IL-6
and IL-8 may contribute to the generation of wear particles. On
the other hand, particles might cause further damage to the
knee and facilitate further production of proinﬂammatory
cytokines. While human knee has a limited capability of repair
itself, damage to human knees accelerates. The interactions
between wear particles and cytokines could be complex and
further in vitro and animal studies are warranted to determine
their role in OA progression. In their study, it was demon-
strated that size of particles played an important role in the
level of IL-6 and IL-8 observed. The size of the wear particle
could also act as a possible indicator of the condition of the
human knee.
Collagen makes up 20% of cartilage in wet weight and
proteoglycan constitutes of 7%. As the wear products of the
articular cartilage, wear particles probably contain more content of
collagen than proteoglycans. Previous studies reported that IL-6
can inhibit the expression of type II collagen and IL-8 promotes
loss of proteoglycans. Therefore, wear particles may interact with
the cytokines in human knees, However, future analysis is required
to determine whether the composition of wear particles have an
effect on OA progression.As IL-6 and IL-8 were possibly directly involving in the
disease process and associated with the different characteristics
of the wear particles, it was observable that the properties of
wear particles may also inﬂuence the disease process and drive
the deterioration process causing damage to the knee [122]. IL-
6 is a pro-inﬂammatory cytokine secreted by macrophages that
promotes inﬂammatory changes in the synovium and caused
tissue damage. While IL-8 is a major chemotactic factor that
attracts more inﬂammatory cells to sites of inﬂammation.
Therefore, the larger, rougher and stiffer the particles were,
the more damage and higher production of cytokines there
would be in the early stages of OA.
It is believed that wear particles may be phagocytosed by
macrophages. Human macrophages are approximately 21 mm
in size. Production of IL-6 may induce proteolytic cleavage of
the knee joint tissue. Macrophages are usually the ﬁrst cells to
release IL-8 to attract other cells. In the process, the majority of
wear particles smaller than macrophages might be treated as
cellular debris or an aggregate by these cells. These wear
particles thus might be engulfed by the macrophages and may
stimulate the inﬂammatory response. There is also a possibility
that wear particles become involved in initiating a secondary
inﬂammatory process. The associations between the features of
wear particles (e.g., size, Sa and adhesion) and levels of IL-6
and IL-8 support the above model [122]. The progression of
OA features was, for the ﬁrst time, described using combined
information including the surface roughness and stiffness of
wear particles, and detectable levels of cytokines in synovial
ﬂuid as well as clinical symptoms [108]. Supporting existing
OA features (e.g., depletion of PGs and disruption of collagen
meshwork), new features using the properties of wear particles
and detectable levels of cytokines, and combined with clinical
symptoms can be revealed.
4.2. Analysis of biomarker in OA process
A biomarker is “objectively measured and evaluated as an
indicator of normal biologic processes, pathogenic processes,
or pharmacologic responses to a therapeutic intervention”
[123]. Molecular biomarkers can be involved in synthesis
and degradation, or are more inﬂammatory in nature.
Molecular biomarkers of cartilage metabolism can be used
to measure synthesis and breakdown of collagen and non-
collagen structures in cartilage [124,125]. Type II collagen and
aggrecan are the two main components of the cartilage matrix.
They are nearly speciﬁc to cartilage and thus have potential to
be used as biochemical markers [14]. This information is
useful for OA diagnosis, and for monitoring the disease or
prediction of its progression.
The procollagen type II C-propeptide (PIICP) and type IIA
collagen (PIIANP)/type IIB collagen (PIINP) are measure-
ments of the synthesis of type II collagen. They are good
indicators of cartilage synthesis. For example, higher levels of
PIICP were found in human knee synovial ﬂuid with OA
[124]. PIIANP was shown to correlate to chondrocytes in
human OA cartilage. The association between PIIANP levels
and synovial ﬂuid has not been established.
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of OA [124]. Biomarkers for the degradation of type II
collagen include the type II collagen C-telopeptide fragments
(CTX-II), type II collagen degradation (C2C)/urine C2C (u
C2C), Col CEQ (a marker of type II collagen degradation),
type II collagen helical peptide (Helix-II), type II collagen
neoepitope (uTIINE), and Coll-2-1/Coll-2-1 NO2. CTX-II and
Col CEQ levels were higher in OA synovial ﬂuid than those in
normal joints [124,126]. An increase of synovial ﬂuid uCTX-II
associated with a decrease in PIIANP could predict progres-
sion of OA [126]. C2C/u2C/C had no correlation with severity
of OA [124,127]. It remains to be investigated how Helix-II,
uTIINE and Coll-2-1/Coll-2-1 NO2 interact in the progression
of OA [124].
Non-collagen markers have also been used to assess OA
progression, including proteoglycans, chondroitin sulfate, keratan-
sulfate, markers of proteoglytic enzyme and non-collagenous and
non-proteoglycan glycoproteins [125]. Aggrecan, one of the main
components of proteoglycan, was shown to decrease in early OA.
MMPs may be responsible for the loss of aggrecan within cartilage
in severe, late-stage OA. Higher levels of three chondroitin sulfates
(7d4, 3b3 and cs846) were detected in OA synovial ﬂuid compared
to controls. Cartilage oligomeric matrix protein (COMP), one of
the non-collagenous, non-proteoglycan glycoproteins, increased in
early stage OA. The ratio of proteoglycan/cartilage COMP is
independent of ﬂuid volume and was higher in the OA joint [116].
Analysis of the COMP concentration in normal and diseased horse
joints suggested that the fragment pattern and the absolute COMP
concentration may be useful in monitoring joint diseases [128].
Other molecular structures found in synovial ﬂuid have been
investigated for prediction of knee OA. For example, synovial
ﬂuid osteoprotegerin (OPG) correlates with the severity of the
disease. A high level of OPG was related to the severity of the
primary knee OA [129]. The concentration of OPG/osteoclas-
togenesis inhibitory factor (OCIF) in synovial ﬂuid increased
with OA progression [130]. Osteopontin (OPN) may be used
as a biomarker to the progression of knee OA [131,132]. The
mean plasma OPN concentration was signiﬁcantly higher in
OA joints than those in healthy control ones [131]. OPN levels
in synovial ﬂuid from OA patients were higher than in healthy
controls [132]. OPN in synovial ﬂuid and articular cartilage
successfully correlated to OA progression in human knee
joints [132]. Endoglin in synovial ﬂuid was also associated
with knee OA severity [133]. However, although investigated,
the levels of serum transforming growth factor-beta 1 (TGF-
β1) [134] were not sensitive to status of knee OA. It has been
reported that P selectin, an adhesion molecule which can
mediate the rolling and adhesion between the endothelial and
the neutrophils, in synovial ﬂuid had signiﬁcant correlation to
the severity of OA [135]. Leukotriene B4 and prostaglandin E2
like activity levels in osteoarthritic synovial ﬂuid were higher
than in normal joints [136].
4.3. Summary
Cytokines released from the inﬂamed synovium were
investigated for OA study. It was found that changes in thelevels can reﬂect OA degradation. Recent ﬁndings indicated
that the larger, rougher and stiffer the particles were, the more
damage and higher production of cytokines there would be in
the early stages of OA. Wear particle found in human knee
joint may inﬂuence the concentrations of these cytokines. To
further understand OA process, a comprehensive study with
samples in the different OA grades collected from age matched
participants will enable the further understanding of the
association between the properties of wear particles and the
inﬂammatory changes they may participate in OA. Properties
of wear particle may be useful markers to not only grade OA
but also have prognostic value.
Biomarkers in synovial ﬂuid have a speciﬁc and sensitive
ability to present the abnormalities of the joint in monitoring
and diagnosing osteoarthritis. For example, assay of synovial
ﬂuid has a sensitivity of 84% and a speciﬁcity of 90% in
diagnosis of joint pathology [37]. However, it is rather
complicated [137]. The challenges in the use of biomarkers
as summarized below. Firstly, current biomarkers are not
sensitive enough to diagnose the status of degenerated joints
such as the levels of TGF-β1 [134,138]. Secondly, many
inﬂuential factors act on biomarkers, namely, liver and kidney
clearance, circadian rhythms, intestinal peristalsis, exercise
level, age, breed, diet, sex, drug administration, surgery, and
general anesthesia, making the assay very complex [5].
Further, sample collection and storage methods also impact
on the assay. In summary, the use of biomarkers in synovial
ﬂuid for the assessment of OA progression is complicated as
there are numerous biological factors that inﬂuence their
presence in the synovial ﬂuid and their sensitivity. The use
of biomarkers in the assessment of OA is in its infancy and
requires further investigation. A single biomarker for early
diagnosis of OA is insufﬁcient and a group of biomarkers may
be required [124].5. Conclusions and future work
Wear in the human knee is a main cause of OA. In the
process, knee joints suffer changes and functions such as
cartilage degradation, subchondral bone remodeling and
inﬂammation. Investigations to cartilage, synovial ﬂuid and
wear products found in human knee will assist further under-
standing of wear in human knees. OA is a disease involving
metabolic, biochemical and biomechanical factors. Investiga-
tions from these aspects will aid the changes to wear in human
knees. Also, it has been realized that OA starts at the
nanometer scale and therefore more work is required to
study the mechanical properties and surface morphologies in
this scale.References
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